These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4852457)

  • 1. Inhalation, parenteral and oral LD50 values of delta 9-tetrahydrocannabinol in Fischer rats.
    Rosenkrantz H; Heyman IA; Braude MC
    Toxicol Appl Pharmacol; 1974 Apr; 28(1):18-27. PubMed ID: 4852457
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic oral toxicity of cannabinoids in rats.
    Thompson GR; Mason MM; Rosenkrantz H; Braude MC
    Toxicol Appl Pharmacol; 1973 Jul; 25(3):373-90. PubMed ID: 4738002
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute, subacute and 23-day chronic marihuana inhalation toxicities in the rat.
    Rosenkrantz H; Braude M
    Toxicol Appl Pharmacol; 1974 Jun; 28(3):428-41. PubMed ID: 4850426
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys.
    Thompson GR; Rosenkrantz H; Schaeppi UH; Braude MC
    Toxicol Appl Pharmacol; 1973 Jul; 25(3):363-72. PubMed ID: 4199474
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral delta9-tetrahydrocannabinol toxicity in rats treated for periods up to six months.
    Rosendrantz H; Sprague RA; Fleischman RW; Braude C
    Toxicol Appl Pharmacol; 1975 May; 32(2):399-417. PubMed ID: 1171539
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological activity of the basic fraction of marihuana whole smoke condensate alone and in combination with delta-9-tetrahydrocannabinol in mice.
    Johnson JM; Lemberger L; Novotny M; Forney RB; Dalton WS; Maskarinec MP
    Toxicol Appl Pharmacol; 1984 Mar; 72(3):440-8. PubMed ID: 6324414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of orally administered delta-9-tetrahydrocannabinol in man.
    Hosko MJ; Kochar MS; Wang RI
    Clin Pharmacol Ther; 1973; 14(3):344-52. PubMed ID: 4698562
    [No Abstract]   [Full Text] [Related]  

  • 8. The lethal effects of delta9-tetrahydrocannabinol in mice enhanced by pretreatment with SKF 525-A or chloramphenicol.
    Sofia RD
    Eur J Pharmacol; 1974 May; 26(2):383-5. PubMed ID: 4854932
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic delta9-tetrahydrocannabinol in rats: effect on social interactions, mouse killing, motor activity, consummatory behavior, and body temperature.
    Miczek KA
    Psychopharmacology (Berl); 1979 Jan; 60(2):137-46. PubMed ID: 106423
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral and intravenous toxicity of delta9-tetrahydrocannabinol in rhesus monkeys.
    Thompson GR; Fleischman RW; Rosenkrantz H; Braude MC
    Toxicol Appl Pharmacol; 1974 Mar; 27(3):648-65. PubMed ID: 4212215
    [No Abstract]   [Full Text] [Related]  

  • 11. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part II: comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents.
    Manwell LA; Ford B; Matthews BA; Heipel H; Mallet PE
    J Pharmacol Toxicol Methods; 2014; 70(1):112-9. PubMed ID: 24956154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and subacute interactions between delta9-tetrahydrocannabinol and other drugs in the rat.
    Pryor GT; Husain S; Mitoma C
    Ann N Y Acad Sci; 1976; 281():171-89. PubMed ID: 1071364
    [No Abstract]   [Full Text] [Related]  

  • 13. Tolerance to the behavioral and hypothermic effects of 1- 9-tetrahydrocannabinol in neonatal chicks.
    Abel EL; McMillan DE; Harris LS
    Experientia; 1972 Oct; 28(10):1188-9. PubMed ID: 5087032
    [No Abstract]   [Full Text] [Related]  

  • 14. Subacute toxicity of aqueous-suspended 9 -tetrahydrocannabinol in rats.
    Phillips RN; Brown DJ; Martz R; Hubbard JD; Forney RB
    Toxicol Appl Pharmacol; 1972 May; 22(1):45-9. PubMed ID: 5064307
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypothermic action of delta 9-tetrahydrocannabinol, 11-hydroxy-delta 9-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
    Haavik CO; Hardman HF
    Life Sci; 1973 Dec; 13(12):1771-8. PubMed ID: 4777336
    [No Abstract]   [Full Text] [Related]  

  • 16. Respiratory effects of delta-9-tetrahydrocannabinol.
    Bellville JW; Swanson GD; Aqleh KA
    Clin Pharmacol Ther; 1975 May; 17(5):541-8. PubMed ID: 1126111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lethal effects of 1 -tetrahydrocannabinol in aggregated and isolated mice following single dose administration.
    Sofia RD
    Eur J Pharmacol; 1972 Oct; 20(1):139-42. PubMed ID: 4637942
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral and parenteral formulations of marijuana constituents.
    Rosenkrantz H; Thompson GR; Braude MC
    J Pharm Sci; 1972 Jul; 61(7):1106-12. PubMed ID: 4625586
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of (-)delta 9-trans-tetrahydrocannabinol on social behavior of squirrel monkey dyads in a water competition situation.
    Jones BC; Clark DL; Consroe PF; Smith HJ
    Psychopharmacologia; 1974 Jun; 37(1):37-43. PubMed ID: 4213066
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhaled delivery of Δ(9)-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology.
    Nguyen JD; Aarde SM; Vandewater SA; Grant Y; Stouffer DG; Parsons LH; Cole M; Taffe MA
    Neuropharmacology; 2016 Oct; 109():112-120. PubMed ID: 27256501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.